A study on sarcopenia induced by anti-cancer molecular targeted agents
Not Applicable
- Conditions
- malignancies indicated for molecular targeted agents
- Registration Number
- JPRN-UMIN000019477
- Lead Sponsor
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Not provided
Exclusion Criteria
1 patients contraindicated for molecular targeted agent 2 serious complications or comorbidities
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method longitudinal change in body composition induced by molecular targeted agents
- Secondary Outcome Measures
Name Time Method search for biomarker